Research
Seasonal mass vaccination with R21 malaria vaccine effective in reducing malaria infection
The Brief
- A new study published in The Lancet reports that seasonal mass vaccination with the R21 malaria vaccine before the rainy season can reduce the odds of malaria infection by up to 70%.
- The vaccination is used alongside existing malaria control tools.
- The source describes the findings as coming from a single new study, reported by Medical Xpress on 2026-11-20.
Why it matters
The finding suggests a community-wide, seasonally timed vaccination strategy could complement existing malaria control measures, which matters for public health planners and researchers evaluating malaria prevention.
Who’s affected
- public health researchers and malaria control programmes
- health policymakers in malaria-endemic regions
Vaccinating whole communities with the malaria vaccine R21 before the rainy season, alongside existing malaria control tools, can reduce the odds of infection by up to 70%, according to a new study published in The Lancet.